186 related articles for article (PubMed ID: 36077251)
1. Establishment and Characterization of Novel Human Intestinal In Vitro Models for Absorption and First-Pass Metabolism Studies.
Przybylla R; Mullins CS; Krohn M; Oswald S; Linnebacher M
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077251
[TBL] [Abstract][Full Text] [Related]
2. Functional Comparison of Human Colonic Carcinoma Cell Lines and Primary Small Intestinal Epithelial Cells for Investigations of Intestinal Drug Permeability and First-Pass Metabolism.
Yamaura Y; Chapron BD; Wang Z; Himmelfarb J; Thummel KE
Drug Metab Dispos; 2016 Mar; 44(3):329-35. PubMed ID: 26700954
[TBL] [Abstract][Full Text] [Related]
3. Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells.
Habano W; Gamo T; Terashima J; Sugai T; Otsuka K; Wakabayashi G; Ozawa S
BMC Cancer; 2011 Feb; 11():81. PubMed ID: 21342487
[TBL] [Abstract][Full Text] [Related]
4. Baicalin pharmacokinetic profile of absorption process using novel in-vitro model: cytochrome P450 3A4-induced Caco-2 cell monolayers combined with rat intestinal rinse fluids.
Morisaki T; Hou XL; Takahashi K; Takahashi K
J Pharm Pharmacol; 2013 Oct; 65(10):1526-35. PubMed ID: 24028620
[TBL] [Abstract][Full Text] [Related]
5. Generation of tetracycline-controllable CYP3A4-expressing Caco-2 cells by the piggyBac transposon system.
Ichikawa M; Akamine H; Murata M; Ito S; Takayama K; Mizuguchi H
Sci Rep; 2021 Jun; 11(1):11670. PubMed ID: 34083621
[TBL] [Abstract][Full Text] [Related]
6. Deconvolution of Cytochrome P450 Induction Mechanisms in HepaRG Nuclear Hormone Receptor Knockout Cells.
Preiss LC; Liu R; Hewitt P; Thompson D; Georgi K; Badolo L; Lauschke VM; Petersson C
Drug Metab Dispos; 2021 Aug; 49(8):668-678. PubMed ID: 34035124
[TBL] [Abstract][Full Text] [Related]
7. New insights into drug absorption: studies with sirolimus.
Paine MF; Leung LY; Watkins PB
Ther Drug Monit; 2004 Oct; 26(5):463-7. PubMed ID: 15385826
[TBL] [Abstract][Full Text] [Related]
8. Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines.
Pfrunder A; Gutmann H; Beglinger C; Drewe J
J Pharm Pharmacol; 2003 Jan; 55(1):59-66. PubMed ID: 12625868
[TBL] [Abstract][Full Text] [Related]
9. The effects of culture conditions on CYP3A4 and MDR1 mRNA induction by 1alpha,25-dihydroxyvitamin D(3) in human intestinal cell lines, Caco-2 and LS180.
Aiba T; Susa M; Fukumori S; Hashimoto Y
Drug Metab Pharmacokinet; 2005 Aug; 20(4):268-74. PubMed ID: 16141606
[TBL] [Abstract][Full Text] [Related]
10. PXR/CYP3A4-humanized mice for studying drug-drug interactions involving intestinal P-glycoprotein.
Holmstock N; Gonzalez FJ; Baes M; Annaert P; Augustijns P
Mol Pharm; 2013 Mar; 10(3):1056-62. PubMed ID: 23360470
[TBL] [Abstract][Full Text] [Related]
11. A doxycycline-inducible CYP3A4-Caco-2 cell line as a model for evaluating safety of aflatoxin B1 in the human intestine.
Bai L; Tachibana K; Murata M; Inoue T; Mizuguchi H; Maeda S; Ikemura K; Okuda M; Kusakabe T; Kondoh M
Toxicol Lett; 2022 Nov; 370():1-6. PubMed ID: 36100150
[TBL] [Abstract][Full Text] [Related]
12. Development of Caco-2 cells expressing four CYPs via a mammalian artificial chromosome.
Ohta Y; Kazuki K; Abe S; Oshimura M; Kobayashi K; Kazuki Y
BMC Biotechnol; 2020 Aug; 20(1):44. PubMed ID: 32819341
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of P-glycoprotein, MRP2, and CYP3A4 impairs intestinal absorption of octreotide in rats with portal hypertension.
Sun X; Tang S; Hou B; Duan Z; Liu Z; Li Y; He S; Wang Q; Chang Q
BMC Gastroenterol; 2021 Jan; 21(1):2. PubMed ID: 33407159
[TBL] [Abstract][Full Text] [Related]
14. Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor.
Schmiedlin-Ren P; Thummel KE; Fisher JM; Paine MF; Watkins PB
Drug Metab Dispos; 2001 Nov; 29(11):1446-53. PubMed ID: 11602520
[TBL] [Abstract][Full Text] [Related]
15. Intestinal first-pass metabolism by cytochrome p450 and not p-glycoprotein is the major barrier to amprenavir absorption.
Dufek MB; Bridges AS; Thakker DR
Drug Metab Dispos; 2013 Sep; 41(9):1695-702. PubMed ID: 23821186
[TBL] [Abstract][Full Text] [Related]
16. CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies.
Engman HA; Lennernäs H; Taipalensuu J; Otter C; Leidvik B; Artursson P
J Pharm Sci; 2001 Nov; 90(11):1736-51. PubMed ID: 11745731
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of the impact of membrane permeability on intestinal first-pass metabolism of CYP3A substrates.
Yasugi Y; Shirasaka Y; Tamai I
Biopharm Drug Dispos; 2024 Feb; 45(1):3-14. PubMed ID: 38085672
[TBL] [Abstract][Full Text] [Related]
18. Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human Hepatocytes.
Hendriks DFG; Vorrink SU; Smutny T; Sim SC; Nordling Å; Ullah S; Kumondai M; Jones BC; Johansson I; Andersson TB; Lauschke VM; Ingelman-Sundberg M
Clin Pharmacol Ther; 2020 Oct; 108(4):844-855. PubMed ID: 32320483
[TBL] [Abstract][Full Text] [Related]
19. Investigating the Utility of Humanized Pregnane X Receptor-Constitutive Androstane Receptor-CYP3A4/7 Mouse Model to Assess CYP3A-Mediated Induction.
Ly JQ; Wong S; Liu L; Li R; Messick K; Chang JH
Drug Metab Dispos; 2021 Jul; 49(7):540-547. PubMed ID: 33863817
[TBL] [Abstract][Full Text] [Related]
20. Novel In Vitro Models for Cell Differentiation and Drug Transport Studies of the Human Intestine.
Przybylla R; Krohn M; Sellin ML; Frank M; Oswald S; Linnebacher M
Cells; 2023 Sep; 12(19):. PubMed ID: 37830585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
